SCHEMBL2907434

SCHEMBL2907434

Nc1nc(NCCCn2ccc(-c3ccc(Cl)cc3Cl)c2C(=O)NCCN2CCCCC2)ccc1[N+](=O)[O-]

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 4/20 0.48
GSK3A P49840 3/20 0.48
CDK1 P06493 2/20 0.45
CCNB2 O95067 1/20 0.42
CCNB1 P14635 1/20 0.42
CCNB3 Q8WWL7 1/20 0.42
DPP4 P27487 1/20 0.41
DPP8 Q6V1X1 1/20 0.41
CYP2C19 P33261 1/20 0.40
LMNA P02545 2/20 0.39
KCNH2 Q12809 1/20 0.36
SIGMAR1 Q99720 1/20 0.36
ALDH1A1 P00352 3/20 0.36
CACNA1G O43497 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
MAPT P10636 1/20 0.35
KLK7 P49862 1/20 0.35
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2912010 0.99 GSK3B (0.49) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2907721 0.96 GSK3B (0.49) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2910328 0.93 CYP2C19 (0.50) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2910865 0.90 LMNA (0.53) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2904895 0.90 GSK3B (0.48) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2912039 0.88 GSK3B (0.48) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2910387 0.87 GSK3B (0.47) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2907104 0.86 GSK3B (0.49) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2913404 0.86 GSK3B (0.48) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2908870 0.86 GSK3B (0.48) GSK3BGSK3ACDK1CCNB2CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537099-B1 PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 NOVARTIS VACCINES & DIAGNOSTIC (US) 2010-08-11 EP disclosed